F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.160-Protect Medical Innovation Act of 2015. S.149-Medical Device Access and Innovation Protection Act. HR.6-21st Century Cures Act. Yet to be introduced House proposal to have the FDA regulate laboratory developed tests. Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests. H.R. 771-Protecting Access to Diabetes Supplies Act of 2015. Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies. HCR Competitive Bidding. H.R.6-21st Century Cures Act; Yet to be introduced House proposal to have the FDA regulate laboratory developed tests; Yet to be introduced Senate proposal to have the FDA regulate laboratory developed tests; H.R. 771-Protecting Access to Diabetes Supplies Act of 2015; Yet to be introduced Senate proposal on Medicare competitive bidding proposal related to diabetes supplies. Monitored Congressional actions on HR 6, 21st Century Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL CONWELL RING | — |
| BRUCE THOMAS TAYLOR | — |
| RAVI UPADHYAY New | — |
Medicare/Medicaid MMM
Legislation affecting the Medicare DMEPOS competitive bidding program. Legislation affecting Medicare payment for laboratory services.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RUSSELL CONWELL RING | — |
| RAVI UPADHYAY New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.